Skip to content
10-Q

Quarterly Report

BIOMERICA, INC. BMRA

0001493152-26-016388

← back to feed
Filed
Apr 13, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2026 · Apr 13, 2026 3.09M sh
Shares Diluted Q3 2026 · Feb 28, 2026 3.01M sh
Shares Diluted Q3 2026 · Feb 28, 2026 2.85M sh
Shares Diluted restated Q3 2026 · Feb 28, 2025 2.4M sh
Shares Diluted restated Q3 2026 · Feb 28, 2025 2.33M sh
Operating Cash Flow Q3 2026 · Feb 28, 2026 −$2.51M
Operating Cash Flow Q3 2026 · Feb 28, 2025 −$3.18M
Cash And Equivalents Q3 2026 · Feb 28, 2026 $1.34M
Cash And Equivalents Q3 2026 · May 31, 2025 $3.06M
Cash And Equivalents Q3 2026 · May 13, 2025 $2.4M
Stockholders Equity Q3 2026 · Feb 28, 2026 $3.32M
Stockholders Equity Q3 2026 · Nov 30, 2025 $4.44M
Stockholders Equity Q3 2026 · Aug 31, 2025 $5.16M
Stockholders Equity Q3 2026 · May 31, 2025 $4.11M
Stockholders Equity Q3 2026 · May 13, 2025 $4.11M
Stockholders Equity Q3 2026 · Feb 28, 2025 $5.53M
Stockholders Equity Q3 2026 · Nov 30, 2024 $5.11M
Stockholders Equity Q3 2026 · Aug 31, 2024 $5.35M
Stockholders Equity Q3 2026 · May 31, 2024 $6.59M
Current Liabilities Q3 2026 · Feb 28, 2026 $1.56M
Current Liabilities Q3 2026 · May 13, 2025 $1.74M
Total Liabilities Q3 2026 · Feb 28, 2026 $1.56M
Total Liabilities Q3 2026 · May 13, 2025 $1.84M
Current Assets Q3 2026 · Feb 28, 2026 $4.12M
Current Assets Q3 2026 · May 13, 2025 $4.88M
Total Assets Q3 2026 · Feb 28, 2026 $4.88M
Total Assets Q3 2026 · May 13, 2025 $5.95M
Eps Diluted Q3 2026 · Feb 28, 2026 −$0.44
Eps Diluted Q3 2026 · Feb 28, 2026 −$0.92
Eps Diluted restated Q3 2026 · Feb 28, 2025 −$0.48
Eps Diluted restated Q3 2026 · Feb 28, 2025 −$1.47
Eps Basic Q3 2026 · Feb 28, 2026 −$0.44
Eps Basic Q3 2026 · Feb 28, 2026 −$0.92
Eps Basic restated Q3 2026 · Feb 28, 2025 −$0.48
Eps Basic restated Q3 2026 · Feb 28, 2025 −$1.47
Sga Expense Q3 2026 · Feb 28, 2026 $1.08M
Sga Expense Q3 2026 · Feb 28, 2026 $3.64M
Sga Expense Q3 2026 · Feb 28, 2025 $1.01M
Sga Expense Q3 2026 · Feb 28, 2025 $3.54M
Rd Expense Q3 2026 · Feb 28, 2026 $178K
Rd Expense Q3 2026 · Feb 28, 2026 $583K
Rd Expense Q3 2026 · Feb 28, 2025 $217K
Rd Expense Q3 2026 · Feb 28, 2025 $771K
Net Income Q3 2026 · Feb 28, 2026 −$1.31M
Net Income Q3 2026 · Feb 28, 2026 −$2.63M
Net Income Q3 2026 · Nov 30, 2025 −$1.32M
Net Income Q3 2026 · Aug 31, 2025 $2K
Net Income Q3 2026 · Feb 28, 2025 −$1.16M
Net Income Q3 2026 · Feb 28, 2025 −$3.43M
Net Income Q3 2026 · Nov 30, 2024 −$950K
Net Income Q3 2026 · Aug 31, 2024 −$1.32M
Operating Income Q3 2026 · Feb 28, 2026 −$1.3M
Operating Income Q3 2026 · Feb 28, 2026 −$3.79M
Operating Income Q3 2026 · Feb 28, 2025 −$1.21M
Operating Income Q3 2026 · Feb 28, 2025 −$3.57M
Gross Profit Q3 2026 · Feb 28, 2026 −$44K
Gross Profit Q3 2026 · Feb 28, 2026 $433K
Gross Profit Q3 2026 · Feb 28, 2025 $19K
Gross Profit Q3 2026 · Feb 28, 2025 $742K
Cost Of Revenue Q3 2026 · Feb 28, 2026 $1.03M
Cost Of Revenue Q3 2026 · Feb 28, 2026 $3.15M
Cost Of Revenue Q3 2026 · Feb 28, 2025 $1.1M
Cost Of Revenue Q3 2026 · Feb 28, 2025 $3.82M
Revenue Q3 2026 · Feb 28, 2026 $987K
Revenue Q3 2026 · Feb 28, 2026 $3.58M
Revenue Q3 2026 · Feb 28, 2025 $1.12M
Revenue Q3 2026 · Feb 28, 2025 $4.56M